Expansion of unusual CD4+ T cells in severe rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1106-1114

  Martens, Peter B ^a   Goronzy, Jörg J ^a   Schaid, Daniel ^a   Weyand, Cornelia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN;

ANALYTIC METHOD; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL SORTER; GENETIC RISK; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOCYTE COUNT; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, CD28; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL COMPARTMENTATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 0030980997     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400615     Document Type: Article

References (29)

1. Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735, 1992
2. Van Boxel JA, Paget SA: Predominantly T cell infiltrate in rheumatoid synovial membranes. N Engl J Med 293:517-520, 1975
3. Winchester R: The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 56:389-466, 1994
4. Nepom GT, Nepom BS: Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am 18:785-792, 1992
5. Matteson EL, Yocum DE, St. Clair EW, Achkar AA, Thakor MS, Jacobs MR, Hays AE, Heitman CK, Johnston JM: Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection. Arthritis Rheum 38:1187-1193, 1995
6. Moreland LW, Bucy RP, Tilden A, Pratt PW, LoBuglio AF, Khazeli M, Everson MP, Daddona P, Ghrayeb J, Kilgarriff C, Sanders ME, Koopman WJ: Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum 36:307-318, 1993
7. Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento EP, Colvin RB, Duquesnoy RJ, Kurnick JT: Clonal dominance among T lymphocyte infiltrates in arthritis. Proc Natl Acad Sci USA 85:1179-1183, 1988
8. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL: Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253:325-329, 1991
9. Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, Carlo DJ, Brostoff SW: Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci U S A 88:10921-10925, 1991
10. Williams WV, Fang Q, Demarco D, VonFeldt J, Zurier RB, Weiner DB: Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium. J Clin Invest 90:326-333, 1992
11. Goronzy JJ, Weyand CM: T cells in rheumatoid arthritis. Rheum Dis Clin North Am 21:655-674, 1995
12. Schmidt D, Goronzy JJ, Weyand CM: CD4 + CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027-2037, 1996
13. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191-212, 1993
14. Waase I, Kayser C, Carlson PJ, Goronzy JJ, Weyand CM: Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum 39:904-913, 1996
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
16. S.A.G.E.: Statistical Analysis for Genetic Epidemiology, Release 2.2. New Orleans, LSU Medical Center, 1994
17. Todd JA, Acha-Orbea H, Bell JI: A molecular basis for major histocompatibility complex class II-associated autoimmunity. Science 240:1003-1009, 1988
18. Goronzy JJ, Bartz-Bazzanella P, Hu W, Jendro MC, Walser-Kuntz DR, Weyand CM: Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest 94:2068-2076, 1994
19. Crabtrec GR: Contingent genetic regulatory events in T lymphocyte activation. Science 243:355-361, 1989
20. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279-289, 1994
21. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MD, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-x(L). Immunity 3:87-98, 1995
22. Mueller DL, Jenkins MK: Molecular mechanisms underlying functional T-cell unresponsiveness. Curr Opin Immunol 7:375-381, 1995
23. Goronzy JJ, Weyand CM: Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol 6:290-294, 1994
24. Park W, Weyand CM, Schmidt D, Goronzy JJ: Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells. Eur J Immunol (in press)
25. Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95:2120-2126, 1995
26. Weyand CM, Hicok KC, Conn DL, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117:801-806, 1992
27. Wordsworth P, Pile KD, Buckely JD, Lanchbury JS, Ollier B, Lathrop M, Bell JI: HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 51:585-591, 1992
28. Nepom GT, Nepom BS: Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping, Rheum Dis Clin North Am 18:785-792, 1992
29. Weyand CM, Xie C, Goronzy JJ: Homozygosity for the HLADRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 89:2033-2039, 1992